ANUH PHARMA
|
ANUH PHARMA Last 5 Year Financial Ratios History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 9.45 | 11.98 | 7.22 | 6.10 | 5.67 |
| CEPS(Rs) | 5.60 | 6.85 | 4.58 | 4.24 | 4.34 |
| DPS(Rs) | 1.50 | 2.50 | 2.00 | 1.75 | 1.50 |
| Book NAV/Share(Rs) | 65.06 | 58.11 | 48.14 | 42.66 | 38.04 |
| Tax Rate(%) | 22.38 | 23.31 | 23.78 | 21.88 | 26.24 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 9.23 | 11.65 | 9.78 | 9.67 | 10.25 |
| EBIT Margin(%) | 9.34 | 12.19 | 9.10 | 8.29 | 9.22 |
| Pre Tax Margin(%) | 9.15 | 12.04 | 8.96 | 7.97 | 8.75 |
| PAT Margin (%) | 7.10 | 9.24 | 6.83 | 6.22 | 6.46 |
| Cash Profit Margin (%) | 8.42 | 10.56 | 8.66 | 8.66 | 9.88 |
| Performance Ratios | |||||
| ROA(%) | 9.97 | 14.14 | 9.63 | 8.99 | 8.63 |
| ROE(%) | 15.34 | 22.56 | 15.90 | 15.11 | 16.12 |
| ROCE(%) | 19.77 | 29.66 | 21.05 | 19.33 | 19.75 |
| Asset Turnover(x) | 1.40 | 1.53 | 1.41 | 1.44 | 1.34 |
| Sales/Fixed Asset(x) | 5.95 | 6.37 | 5.31 | 4.97 | 4.55 |
| Working Capital/Sales(x) | 3.37 | 3.50 | 3.62 | 3.84 | 4.48 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 0.17 | 0.16 | 0.19 | 0.20 | 0.22 |
| Receivable days | 111.12 | 101.36 | 105.71 | 90.17 | 77.87 |
| Inventory Days | 41.04 | 41.55 | 52.54 | 59.98 | 59.23 |
| Payable days | 109.35 | 110.65 | 125.45 | 117.42 | 125.15 |
| Valuation Parameters | |||||
| PER(x) | 7.88 | 10.25 | 11.03 | 14.09 | 15.91 |
| PCE(x) | 13.30 | 17.93 | 8.70 | 10.13 | 10.40 |
| Price/Book(x) | 2.29 | 4.23 | 1.65 | 2.01 | 2.37 |
| Yield(%) | 1.01 | 1.02 | 2.51 | 2.04 | 1.66 |
| EV/Net Sales(x) | 1.11 | 1.89 | 0.74 | 0.86 | 1.03 |
| EV/Core EBITDA(x) | 10.38 | 13.94 | 6.77 | 7.94 | 8.01 |
| EV/EBIT(x) | 11.83 | 15.45 | 8.14 | 10.27 | 10.99 |
| EV/CE(x) | 2.19 | 4.18 | 1.63 | 1.93 | 2.18 |
| M Cap / Sales | 1.13 | 1.90 | 0.76 | 0.89 | 1.05 |
| Growth Ratio | |||||
| Net Sales Growth(%) | 2.24 | 22.66 | 8.39 | 12.66 | 40.72 |
| Core EBITDA Growth(%) | -19.20 | 51.68 | 9.98 | -5.38 | 102.79 |
| EBIT Growth(%) | -21.47 | 64.40 | 18.46 | 0.30 | 98.80 |
| PAT Growth(%) | -21.16 | 66.00 | 18.38 | 7.47 | 98.78 |
| EPS Growth(%) | -21.16 | 66.00 | 18.38 | 7.47 | -0.61 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | 0.03 | 0.01 | - | 0.01 | 0.07 |
| Current Ratio(x) | 2.11 | 2.22 | 1.91 | 1.98 | 1.70 |
| Quick Ratio(x) | 1.69 | 1.72 | 1.46 | 1.37 | 1.12 |
| Interest Cover(x) | 50.10 | 82.82 | 64.61 | 25.76 | 19.99 |
| Total Debt/Mcap(x) | 0.01 | - | - | 0.01 | 0.03 |
Compare Financial Ratios of peers of ANUH PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ANUH PHARMA | ₹876.3 Cr | -3.2% | -11.9% | -15.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹382,466.0 Cr | -3% | -6.8% | -11.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹162,423.0 Cr | -0.5% | -8.4% | 25.1% | Stock Analytics | |
| CIPLA | ₹128,405.0 Cr | -0.2% | 1% | -1.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹120,448.0 Cr | -3.4% | -5.6% | 6.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,408.0 Cr | -1.1% | -2.9% | -9.5% | Stock Analytics | |
ANUH PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ANUH PHARMA | -3.2% |
-11.9% |
-15.9% |
| SENSEX | -2.7% |
-1.3% |
-2.3% |
You may also like the below Video Courses
